International Stem Cell (ISCO) EBT Margin (QoQ) (2010 - 2025)
International Stem Cell (ISCO) EBT Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | International Stem Cell | 2.64 Mn | 1.55 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 835.00 |
| Sep 30, 2025 | 62.00 |
| Jun 30, 2025 | 2,553.00 |
| Mar 31, 2025 | -4,441.00 |
| Dec 31, 2024 | 623.00 |
| Sep 30, 2024 | 1,593.00 |
| Jun 30, 2024 | -926.00 |
| Mar 31, 2024 | 480.00 |
| Dec 31, 2023 | -1,057.00 |
| Sep 30, 2023 | 308.00 |
| Jun 30, 2023 | -809.00 |
| Mar 31, 2023 | -821.00 |
| Dec 31, 2022 | 2,626.00 |
| Sep 30, 2022 | -1,957.00 |
| Jun 30, 2022 | 35.00 |
| Mar 31, 2022 | 1,876.00 |
| Dec 31, 2021 | 3,166.00 |
| Sep 30, 2021 | -171.00 |
| Jun 30, 2021 | -90.00 |
| Mar 31, 2021 | 331.00 |